What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001794543
Total reported value
$1.9B
$1.9B
433 檔
11.3%
During the Q1 2025 filing period, Kathmere Capital Management, LLC (CIK: 0001794543) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $1.9B across 433 reported positions.
In Q1 2025, Kathmere Capital Management, LLC displayed an active expansion posture, initiating 50 new positions and adding to 0 existing holdings, outstripping position reductions.
Showing top 200 holdings (of 433 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VEA | Vanguard Ftse Developed ETF | ETF-Other | 4.17% | -0.03% | +3.46% | |
| 2 | VLUE | Ishares Msci USA Value Facto | ETF-Other | 4.14% | +0.49% | +0.61% | |
| 3 | VV | Vanguard Large-cap ETF | ETF-Other | 3.35% | +0.15% | +1.45% | |
| 4 | VGIT | Vanguard Intermediate-term T | ETF-Other | 3.31% | -0.14% | -5.47% | |
| 5 | QUAL | Ishares Msci USA Quality Fac | ETF-Other | 3.15% | +0.07% | -0.02% | |
| 6 | MTUM | Ishares Msci USA Momentum Fa | ETF-Other | 3.09% | +0.62% | -0.88% | |
| 7 | JEPI | Jpmorgan Equity Premium Inco | ETF-Other | 3.07% | -0.08% | +2.32% | |
| 8 | IBDR | Ishares Ibonds Dec 2026 Term | ETF-Other | 2.23% | -0.15% | +10.03% | |
| 9 | IBDQ | Ishares Ibonds Dec 2025 Term | ETF-Other | 2.23% | — | +9.94% | |
| 10 | IBDS | Ishrs Ibnds Dec 27 CORP ETF | ETF-Other | 2.22% | -0.17% | +9.49% | |
| 11 | IBDT | Ishares Ibonds Dec 2028 ETF | ETF-Other | 2.21% | -0.19% | +8.52% | |
| 12 | AAPL | Apple Inc | Stock-Tech | 2.10% | +0.02% | +34.64% | |
| 13 | IVLU | Ishares Msci International V | ETF-Other | 2.07% | -0.14% | +0.28% | |
| 14 | VWO | Vanguard Ftse Emerging Marke | ETF-Emerging Markets | 1.98% | -0.03% | +4.82% | |
| 15 | DCRE | Dbl Comm Real Est Debt | ETF-Other | 1.75% | — | +27.05% | |
| 16 | JAAA | Janus Henderson Aaa Clo ETF | ETF-Other | 1.75% | — | +27.69% | |
| 17 | GMED | Globus Medical Inc - A | Stock-Healthcare | 1.73% | -0.31% | — | |
| 18 | IBDU | Ishares Ibonds Dec 2029 Term | ETF-Other | 1.65% | -0.15% | +5.41% | |
| 19 | FRDM | Freedom 100 Emeging Mrkt ETF | ETF-Other | 1.53% | +0.09% | -0.30% | |
| 20 | IQLT | Ishares Msci International Q | ETF-Other | 1.46% | -0.03% | +0.91% | |
| 21 | IMTM | Ishares Msci Intl Momentum F | ETF-Other | 1.37% | +0.01% | +1.38% | |
| 22 | TLT | iShares 20+ Year Treasury Bond ETF | ETF-Gov Bonds | 1.20% | — | -14.60% | |
| 23 | IBMP | Ishares Ibonds Dec 2027 Term | ETF-Other | 1.19% | +0.03% | -11.68% | |
| 24 | IBMQ | Ishares Ibonds Dec 2028 Muni | ETF-Other | 1.19% | +0.07% | -11.56% | |
| 25 | IBMO | Ishares Ibonds Dec 2026 Term | ETF-Other | 1.15% | +0.03% | -15.18% | |
| 26 | DSMC | Distillate S/m Cash Flow ETF | ETF-Other | 1.12% | — | +6.06% | |
| 27 | VTV | Vanguard Value ETF | ETF-Other | 1.07% | -0.05% | +7.80% | |
| 28 | WD | Walker & Dunlop Inc | Stock-Other | 1.00% | +0.02% | — | |
| 29 | MSFT | Microsoft CORP | Stock-Tech | 1.00% | -0.08% | +11.79% | |
| 30 | SCHR | Schwab Intermediate-term US | ETF-Other | 0.98% | +0.04% | +117.32% | |
| 31 | VUG | Vanguard Growth ETF | ETF-Other | 0.93% | +0.01% | +4.98% | |
| 32 | FNDE | Schwab Fndmntl Em Mrk Eq ETF | ETF-Other | 0.92% | -0.06% | +0.19% | |
| 33 | MINT | Pimco Enhanced Short Maturit | ETF-Other | 0.91% | -0.05% | +11.56% | |
| 34 | VB | Vanguard Small-cap ETF | ETF-Other | 0.87% | -0.01% | +2.71% | |
| 35 | IBMR | Ishares Ibonds Dec 2029 M Bd | ETF-Other | 0.84% | +0.04% | +151.00% | |
| 36 | SCHF | Schwab Intl Equity ETF | ETF-Other | 0.69% | -0.03% | +4.45% | |
| 37 | BOXX | Alpha Architect 1-3 Mnth Box | ETF-Other | 0.62% | -0.75% | +1.77% | |
| 38 | VUSB | Vanguard Ultra Short Bond Et | ETF-Other | 0.61% | -0.03% | +28.22% | |
| 39 | EFV | Ishares Msci Eafe Value ETF | ETF-Other | 0.58% | -0.07% | -3.32% | |
| 40 | BSCT | Invesco Bulletshares 2029 Cb | ETF-Other | 0.57% | +0.01% | +39.86% | |
| 41 | NVDA | Nvidia CORP | Stock-Tech | 0.53% | +0.03% | +4.70% | |
| 42 | QVAL | Alpha Arch US Qnt Value ETF | ETF-Other | 0.52% | -0.04% | -1.27% | |
| 43 | BRK-B | Berkshire Hathaway Inc-cl B | Stock-Other | 0.51% | -0.02% | -5.77% | |
| 44 | FNDA | Schwab Fndmntl US Sm Co ETF | ETF-Other | 0.48% | -0.01% | +4.64% | |
| 45 | QMOM | Alpha US Quant Mom ETF | ETF-Other | 0.48% | -0.01% | -1.49% | |
| 46 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.47% | -0.04% | +46.01% | |
| 47 | EFG | Ishares Msci Eafe Growth ETF | ETF-Other | 0.45% | -0.02% | -4.16% | |
| 48 | WMT | Walmart Inc | Stock-Consumer Staples | 0.41% | -0.12% | +0.20% | |
| 49 | V | Visa Inc-class A Shares | Stock-Financials | 0.40% | +0.02% | +7.63% | |
| 50 | VTI | Vanguard Total Stock Mkt ETF | ETF-Other | 0.39% | +0.02% | +3.50% |
According to official SEC Form 13F filings, Kathmere Capital Management, LLC reported a total U.S. public equity portfolio value of $1.9B across 433 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including VEA, VLUE, VV) accounted for 11.3% of total reported equity market value during Q1 2025.
Top New Position Initiated
VEA
市值: $49.1M
During Q1 2025, Kathmere Capital Management, LLC's top holdings by market value included VEA (4.2%)、VLUE (4.1%)、VV (3.4%). The largest single position, VEA, represented 4.2% of total portfolio value.
In Q1 2025, Kathmere Capital Management, LLC made 50 total portfolio adjustments, initiating 50 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.